Peak6 Investments LLC Abb Vie Inc. Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $2.93 Million - $3.57 Million	17,900 Added 39.78%	62,900 $12.4 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $1.38 Million - $1.61 Million	-8,900 Reduced 16.51%	45,000 $7.72 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $6.95 Million - $7.92 Million	43,500 Added 418.27%	53,900 $9.82 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $564,160 - $635,377	4,100 Added 65.08%	10,400 $1.61 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $227,103 - $262,905	1,700 Added 36.96%	6,300 $939,000
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $7.54 Million - $9.38 Million	-56,900 Reduced 92.52%	4,600 $619,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $9.78 Million - $11.3 Million	-67,600 Reduced 52.36%	61,500 $9.8 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $15.9 Million - $19.1 Million	115,100 Added 822.14%	129,100 $20.9 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $9.49 Million - $10.9 Million	-70,700 Reduced 83.47%	14,000 $1.88 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $113 Million - $144 Million	-823,700 Reduced 90.68%	84,700 $13 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $146 Million - $181 Million	-1,106,600 Reduced 54.92%	908,400 $147 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $184 Million - $233 Million	1,712,600 Added 566.34%	2,015,000 $273 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $14.8 Million - $16.8 Million	139,400 Added 85.52%	302,400 $32.6 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $8.52 Million - $9.49 Million	81,000 Added 98.78%	163,000 $18.4 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $11 Million - $12.1 Million	-107,660 Reduced 56.76%	82,000 $8.87 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $2.56 Million - $3.46 Million	-31,800 Reduced 14.36%	189,660 $20.3 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $3.1 Million - $3.64 Million	-36,100 Reduced 14.02%	221,460 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $14.6 Million - $19.6 Million	199,460 Added 343.3%	257,560 $25.3 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $586,950 - $889,889	9,100 Added 18.57%	58,100 $4.43 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $5.65 Million - $7.08 Million	-78,400 Reduced 61.54%	49,000 $4.34 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $5.76 Million - $6.92 Million	91,400 Added 253.89%	127,400 $9.51 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $2.29 Million - $2.92 Million	34,800 Added 2900.0%	36,000 $2.62 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $1.45 Million - $1.71 Million	-18,800 Reduced 94.0%	1,200 $97,000
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $1.17 Million - $1.44 Million	-15,000 Reduced 42.86%	20,000 $1.84 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $3.11 Million - $3.46 Million	35,000 New	35,000 $3.31 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account